Drug intelligence / Profile preview

Pyro H-15

Development stage: Unknown
Lead developer: SKM Siddha and Ayurveda Company
Modality: Classical Binding Small Molecules → Small Molecules
Administration: Oral

Overview

Pyro H-15 is a traditional herbal/Ayurvedic formulation developed and marketed by SKM Siddha and Ayurveda Company (India) Private Limited. Launched in 2022, the product is designed for the management of fever and pyrexia, as suggested by its nomenclature. It is manufactured in an ISO GMP certified facility in Erode, Tamil Nadu, India, and is part of a portfolio of over 700 traditional Siddha, Ayurveda, and Unani medicines. The formulation is composed of a blend of natural ingredients and is typically administered in tablet form.

Brand names: Pyro H-15Pyro H-15 Tablet
Other names: Pyro H15

Beyond the preview

Go deeper on Pyro H-15.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pyro H-15.

Explore the full profile